VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $2.35M invested in Pacer BioThreat Strategy ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$24K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| $1.88M | +$24K | +777 | +1% |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $253K | -$439K | -14,173 | -63% |
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $206K | -$34.8K | -1,124 | -14% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$10.1K | +335 | +262% |
|
|
LF
5
Lee Financial
Dallas,
Texas
| – | -$51K | -1,458 | Closed |
|
|
AA
6
Ancora Advisors
Cleveland,
Ohio
| – | -$11K | -203 | Closed |
|